SCHEMBL963631

SCHEMBL963631

CCCCCCCC(=O)CCCC

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.76
MAPT P10636 1/20 0.76
CES2 O00748 4/20 0.65
CES1 P23141 4/20 0.65
GPR84 Q9NQS5 7/20 0.62
PPARG P37231 7/20 0.62
PPARD Q03181 7/20 0.62
PPARA Q07869 7/20 0.62
HDAC11 Q96DB2 5/20 0.62
TSHR P16473 5/20 0.62
PTPN1 P18031 3/20 0.62
ALDH1A1 P00352 3/20 0.62
TLR2 O60603 2/20 0.62
TDP1 Q9NUW8 2/20 0.62
FABP4 P15090 2/20 0.62
SLC22A6 Q4U2R8 1/20 0.62
SLC22A8 Q8TCC7 1/20 0.62
MEN1 O00255 1/20 0.62
ESR1 P03372 1/20 0.62
ALOX15 P16050 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3405859 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL5708548 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL21044627 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL5945790 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL21044676 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL6041084 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL21044655 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL21044682 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL21044632 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84
SCHEMBL8446000 1.00 KMT2A (0.76) KMT2AMAPTCES2CES1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116600803-A Macrocyclic urea orexin receptor agonists 默沙东有限责任公司 2023-08-15 CN claimed
CN-110205201-A A kind of classification method of peony essential oil 西北农林科技大学 2019-09-06 CN claimed
US-20190261627-A1 BIOPOLYMERIC GERMPLASM INTEGUMENTS ALEO BME, INC. 2019-08-29 US claimed
EP-3507280-A2 COALESCING AGENT DERIVED FROM DIOXOLANE DERIVATIVES PTT Global Chemical Public Company Limited (TH) 2019-07-10 EP claimed
CN-107604024-A A kind of method of lipase-catalyzed online synthesis N (5 lauroyl mannoses valeryl) mexiletine 浙江工业大学 2018-01-19 CN claimed
CN-107488691-A A kind of method of lipase-catalyzed online synthesis N (5 lauroyl mannoses valeryl) metoprolol 浙江工业大学 2017-12-19 CN claimed
US-4226996-A 4-SUBSTITUTED-6-OXA-1-AZATRICYCLO/4.2.2.0.2.7/DODECAN-5-ONE SALT THE PURDUE FREDERICK COMPANY (US) 1980-10-07 US claimed
US-4207078-A Diesel fuel containing manganese tricarbonyl and oxygenated compounds TEXACO INC. (US) 1980-06-10 US claimed
US-4083985-A 6-Oxa-1-aza tricyclo dodecan-5-ones as psychomotor stimulators THE PURDUE FREDERICK COMPANY (US) 1978-04-11 US claimed
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2026-03-05 US disclosed
EP-3954745-B1 REVERSIBLY THERMOCHROMIC AQUEOUS INK COMPOSITION FOR WRITING UTENSILS, AND REFILL AND WATER-BASED BALLPOINT PEN EACH INTERNALLY CONTAINING SAME KK PILOT CORPORATION ALSO TRADING AS PILOT CORPORATION (JP) 2026-01-07 EP disclosed
US-20250368596-A1 PROCESS FOR THE DECARBOXYLATIVE KETONIZATION OF C2-C8 CARBOXYLIC ACIDS, DERIVATIVES OR MIXTURES THEREOF SPECIALTY OPERATIONS FRANCE (FR) 2025-12-04 US disclosed
US-12460099-B2 Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment THE PILOT INK CO., LTD. (JP) 2025-11-04 US disclosed
US-12421411-B2 Aqueous ink composition for reversibly thermochromic writing instrument, and refill and aqueous ballpoint pen incorporating aqueous ink composition for reversibly thermochromic writing instrument KABUSHIKI KAISHA PILOT CORPORATION (JP) 2025-09-23 US disclosed
US-4183938-A 1,8-Ethano-5-oxo-octa- and -decahydroquinolines and mydriatic compositions thereof THE PURDUE FREDERICK COMPANY (US) 1980-01-15 US disclosed
EP-0006627-A2 Radiation-sensitive mixture and process for producing relief images HOECHST AKTIENGESELLSCHAFT (DE) 1980-01-09 EP disclosed
US-4083985-A 6-Oxa-1-aza tricyclo dodecan-5-ones as psychomotor stimulators THE PURDUE FREDERICK COMPANY (US) 1978-04-11 US disclosed
US-3976697-A Preparation of tertiary amines TEXACO INC. (US) 1976-08-24 US disclosed
US-3975373-A CYCLOPENTANONE HELVETICOSIDE JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) 1976-08-17 US disclosed
US-3951946-A Cardioglycoside derivatives of the strophanthidin type, a process for their manufacture and medicinal preparations containing these compounds JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT TYR, SCO2, HBB KMT2A 2763/4885MAPT 1195/4885CES2 2932/4885
US-20250368596-A1 PROCESS FOR THE DECARBOXYLATIVE KETONIZATION OF C2-C8 CARBOXYLIC ACIDS, DERIVATIVES OR MIXTURES THEREOF MCCC2, PCCA, PC KMT2A 1357/4885MAPT 2147/4885CES2 537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.